Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Svetlana Shpyro"'
Autor:
Alexander Muik, Jasmin Quandt, Bonny Gaby Lui, Maren Bacher, Sebastian Lutz, Maika Grünenthal, Aras Toker, Jessica Grosser, Orkun Ozhelvaci, Olga Blokhina, Svetlana Shpyro, Isabel Vogler, Nadine Salisch, Özlem Türeci, Ugur Sahin
Publikováno v:
Cell Reports, Vol 43, Iss 8, Pp 114567- (2024)
Summary: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exposure histories become increasingly complex through original and variant-adapted vaccines and infections with viral variants. Upon exposure to the highly altered Omicron spike g
Externí odkaz:
https://doaj.org/article/6d3ec055e6634edda15eec6aea826f60
Autor:
Ai-Min Hui, Jingxin Li, Li Zhu, Rong Tang, Huayue Ye, Mei Lin, Lei Ge, Xiyuan Wang, Fuzhong Peng, Zhenggang Wu, Xiling Guo, Yunfeng Shi, Hongxing Pan, Jiahong Zhu, Zhizhou Song, Jingjun Qiu, Wei Wang, Jianfei Zheng, Orkun Ozhelvaci, Svetlana Shpyro, Meghan Bushway, Evelyna Derhovanessian, Marie-Cristine Kühnle, Ulrich Luxemburger, Alexander Muik, Yoana Shishkova, Zakaria Khondker, Simin Hu, Eleni Lagkadinou, Uğur Şahin, Özlem Türeci, Fengcai Zhu
Publikováno v:
The Lancet Regional Health. Western Pacific, Vol 29, Iss , Pp 100586- (2022)
Summary: Background: BNT162b2, an mRNA vaccine against COVID-19, is being utilised worldwide, but immunogenicity and safety data in Chinese individuals are limited. Methods: This phase 2, randomised, double-blind, placebo-controlled trial included he
Externí odkaz:
https://doaj.org/article/0308eea312194f20ae6eecf0dc7517c4
Autor:
Jingxin Li, Ai-Min Hui, Xiang Zhang, Lei Ge, Yuanzheng Qiu, Rong Tang, Huayue Ye, Xiyuan Wang, Mei Lin, Zhongkui Zhu, Jianfei Zheng, Jingjun Qiu, Eleni Lagkadinou, Svetlana Shpyro, Orkun Ozhelvaci, Özlem Türeci, Zakaria Khondker, Wanrong Yin, Yoana Shishkova, Siyue Jia, Hongxing Pan, Fuzhong Peng, Zhilong Ma, Zhenggang Wu, Xiling Guo, Yunfeng Shi, Alexander Muik, Uğur Şahin, Li Zhu, Fengcai Zhu
Publikováno v:
Advances in therapy. 39(8)
BNT162b1 is a lipid nanoparticle-formulated, nucleoside-modified mRNA SARS-CoV-2 vaccine. Here, we report safety and immune persistence data following a primary two-dose vaccination schedule administered 21 days apart.Immune persistence was determine
Autor:
Alexander Muik, Bonny Gaby Lui, Ann-Kathrin Wallisch, Maren Bacher, Julia Mühl, Jonas Reinholz, Orkun Ozhelvaci, Nina Beckmann, Ramón de la Caridad Güimil Garcia, Asaf Poran, Svetlana Shpyro, Andrew Finlayson, Hui Cai, Qi Yang, Kena A. Swanson, Özlem Türeci, Uğur Şahin
Publikováno v:
Science (New York, N.Y.). 375(6581)
The globally circulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant of concern Omicron (B.1.1.529) has a large number of mutations, especially in the spike protein, indicating that recognition by neutralizing antibodies may
Autor:
Ai-Min Hui, Jing-Xin Li, Li Zhu, Rong Tang, Huayue Ye, Mei Lin, Lei Ge, Xiyuan Wang, Fuzhong Peng, Zhenggang Wu, Xi-Ling Guo, Yunfeng Shi, Hong-Xing Pan, Jiahong Zhu, Zhizhou Song, Jingjun Qiu, Wei Wang, Jianfei Zheng, Orkun Ozhelvaci, Svetlana Shpyro, Meghan Bushway, Evelyna Derhovanessian, Marie-Cristine Kühnle, Ulrich Luxemburger, Alexander Muik, Yoana Shishkova, Zakaria Khondker, Simin Hu, Eleni Lagkadinou, Uğur Şahin, Özlem Türeci, Feng-Cai Zhu
Publikováno v:
SSRN Electronic Journal.
Autor:
Alexander Muik, Bonny Gaby Lui, Ann-Kathrin Wallisch, Maren Bacher, Julia Mühl, Jonas Reinholz, Orkun Ozhelvaci, Nina Beckmann, Ramón de la Caridad Güimil Garcia, Asaf Poran, Svetlana Shpyro, Hui Cai, Qi Yang, Kena A. Swanson, Özlem Türeci, Ugur Sahin
A new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lineage, B.1.1.529, was recently detected in Botswana and South Africa and is now circulating globally. Just two days after it was first reported to the World Health Organization (WHO
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f00dcf26697ce516735cd794caa056e2
https://doi.org/10.1101/2021.12.22.21268103
https://doi.org/10.1101/2021.12.22.21268103